MedPath

Omega-3 fatty acids for ADHD symptoms and learning difficulties in childre

Completed
Conditions
Attention deficit hyperactivity disorder, learning difficulties in 7-12 year old children
Neurological - Other neurological disorders
Registration Number
ACTRN12607000332426
Lead Sponsor
utritional Physiology Research Centre, University of South Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
120
Inclusion Criteria

Children, ADHD diagnosis, parent-reported learning difficulties, willing to fufil requirements of the study.

Exclusion Criteria

Cannot be on stimulant medication, cannot have taken omega-3 supplements for up to 3 months, must not have haemophilia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Conners Parent Rating Scales[Measured at 0, 4, 8 and 12 months.];Cognitive assessments of attention, impulsivity and literacy[Measured at 0, 4, 8 and 12 months.];Erythrocyte omega-3 fatty acid levels[Measured at 0, 4, 8 and 12 months.]
Secondary Outcome Measures
NameTimeMethod
Phospholipase enzyme (PLA2) activity[Measured at baseline.];Eicosanoid levels[Measured at baseline.]
© Copyright 2025. All Rights Reserved by MedPath